A Washington University in St. Louis drug discovery program has received three grants totaling more than $5 million from the National Institutes of Health (NIH) to develop new therapeutics for respiratory diseases. The target illnesses range from the common cold to life-threatening lung disease. 

Enzymes are catalysts that speed up chemical reactions in living organisms and control many cellular biological processes by converting a molecule, or substrate, into a product used by the cell. For scientists, understanding details of how enzymes work is essential to the discovery of drugs to cure diseases and treat disorders.

Study indicates target for future drugs for measles, Ebola, RSV.

One of the most mysterious forms of life may turn out to be a rich and untapped source of antibacterial drugs.

The pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?

This is the inescapable conclusion of Michael Kinch’s adventures in data mining

Thermo Fisher Scientific has developed a high-resolution hydrophobic interaction chromatography (HIC) method that can separate a fusion protein from a truncated version and a structural isomer.

Recently identified cell-cycle controls are targets for new drugs that fight infections by shutting down division.

The previously unrecognized layer of biology could offer new drug targets.

As lab manager at the University of Pittsburgh Drug Discovery Institute (UPDDI), Celeste Reese and her team use high-content imaging strategies and work with many other labs both within the university and outside the university on a wide range of projects.